Tramadol, Urine
Tramadol is a synthetic opioid agonist that possesses an analgesic potency similar to that of codeine, but is considered safer (less respiratory effects) and has less potential for abuse. The typical route of administration is oral, although injectable formulations are available. Tramadol is extensively metabolized. Major metabolites include the inactive metabolite nortramadol and the active metabolite O-desmethyltramadol. This metabolite elicits up to four times the analgesic efficacy of the parent drug tramadol and possesses a longer half-life. The primary metabolic enzyme involved in production of O-desmethyltramadol is CYP2D6. The half-life of tramadol is 4.3-6.7 hours.
Approximately 90% of a single oral dose is eliminated in the urine within 72 hours. Actual elimination depends on factors such as drug formulation dose, dose frequency, clinical status and pharmacokinetics of the individual patient.
Common side effects: nausea, vomiting, dizziness, headache, somnolence, and constipation. Overdose effects include agitation, hypertension, tachycardia, seizures, respiratory depression, coma, and possible death.
Tramadol can be detected in urine by a variety of analytical methods (see below); both qualitative and quantitative tests are available.
- Adherence monitoring
- Drug abuse evaluation
- Toxicity/Overdose assessment
Therapeutic Level: 10-100 ng/mL
Toxic level: >200 ng/mL
Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration is preferred for pharmacokinetic analyses.
Cut-Off Ranges
Cut-off values are used to determine the positivity of the urine specimen being analyzed. Cut-off values can vary based on the particular method of analysis that is used for detection or laboratory, or whether the test is a qualitative method or a quantitative method. Detection will be improved with low cutoff concentrations. The testing laboratory cut-off range is listed on the patient report
Fresh urine specimen (random) collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Creatinine or specific gravity results will identify dilute specimens. Adulteration of the urine specimen can result in erroneous results.
Stability
- Ambient: 3-5 days
- Refrigeration: 5-7 days
- Frozen: 30 days
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Foster City, CA: Biomedical Publications; 2011.
- Brunton LL, Chabner B, Knollman B (eds). Goodman and Gilmans’ the pharmacological basis of therapeutics, 12th ed. New York: McGraw-Hill; 2010.
- Katzung BG, Masters S, Trevor AK (eds). Basic and clinical pharmacology, 12th ed. New York: McGraw-Hill; 2011.